BOLTON SECURITIES CORPORATION’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5K Buy
70
+50
+250% +$8.17K ﹤0.01% 1739
2026
Q2
$3K Buy
+20
New +$2.18K ﹤0.01% 2031
2026
Q1
– Sell
-1,380
Closed -$141K – 2070
2025
Q4
$141K Buy
+1,380
New +$123K 0.01% 884

Other funds holding GH

BOLTON SECURITIES CORPORATION's GH Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Guardant Health (GH) stake by 250% in Q3 2026, buying an estimated $8.17K and bringing the position to 70 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

BOLTON SECURITIES CORPORATION first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $141K in Q4 2025. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 70 shares of Guardant Health worth $12.5K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 50 Guardant Health shares in Q3 2026, an estimated $8.17K.
  • Guardant Health made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1739 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's Guardant Health position peaked at $141K in Q4 2025.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.